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Background: Transition from hospital to home is a critical period for older persons with acute myocardial infarction
(AMI). Home-based secondary prevention programs led by nurses have been proposed to facilitate the patients’
adjustment to AMI after discharge. The objective of this study was to evaluate the effects of a nurse-based case
management for elderly patients discharged after an AMI from a tertiary care hospital.
Methods: In a single-centre randomized two-armed parallel group trial of patients aged 65 years and older
hospitalized with an AMI between September 2008 and May 2010 in the Hospital of Augsburg, Germany, patients
were randomly assigned to a case management or a control group receiving usual care. The case-management
intervention consisted of a nurse-based follow-up for one year including home visits and telephone calls. Key
elements of the intervention were to detect problems or risks and to give advice regarding a wide range of
aspects of disease management (e.g. nutrition, medication). Primary study endpoint was time to first unplanned
readmission or death. Block randomization per telephone call to a biostatistical center, where the randomization
list was kept, was performed. Persons who assessed one-year outcomes and validated readmission data were
blinded. Statistical analysis was based on the intention-to-treat approach and included Cox Proportional Hazards
models.
Results: Three hundred forty patients were allocated to receive case-management (n=168) or usual care (n=172).
The analysis is based on 329 patients (intervention group: n=161; control group: n=168). Of these, 62% were men,
mean age was 75.4 years, and 47.1% had at least either diabetes or chronic heart failure as a major comorbidity.
The mean follow-up time for the intervention group was 273.6 days, and for the control group it was 320.6 days.
During one year, in the intervention group there were 57 first unplanned readmissions and 5 deaths, while the
control group had 75 first unplanned readmissions and 3 deaths. With respect to the endpoint there was no
significant effect of the case management program after one year (Hazard Ratio 1.01, 95% confidence interval
0.72-1.41). This was also the case among subgroups according to sex, diabetes, living alone, and comorbidities.
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Conclusions: A nurse-based management among elderly patients with AMI had no significant influence on the
rate of first unplanned readmissions or death during a one-year follow-up. A possible long-term influence should
be investigated by further studies.
Clinical trial registration: ISRCTN02893746
Keywords: Elderly, Randomized controlled trial, Case management, Myocardial infarctionBackground
The population in Germany, as in many developed coun-
tries, is rapidly ageing [1]. While in 1950, there were 205
million persons aged 60 or over throughout the world, the
global population aged 60 years or over is projected to ex-
pand by more than three times to reach nearly 2 billion in
2050 [1].
Ischemic heart disease is the leading cause of death
among patients in Europe and other regions of the world
[2] and most of the people who die of ischemic heart dis-
ease are 65 years and older [3]. Patients with myocardial
infarction who were discharged alive still are at risk for
postdischarge hospital readmission. Rates for readmission
within 30 days considerably vary among countries with
highest rates observed in the United States (39.1%) and
3.5% reported from Germany [4]. Older age was found to
be a significant predictor of early readmission [5] and a 1-
year readmission rate of 38% in patients > 65 years was re-
ported by Andres et al. [6].
These trends result in a substantial financial burden on
the health care system. Due to the aging of the population
and the improved survival of patients with coronary heart
disease (CHD) a large population of older adults is eligible
for secondary prevention [7].
Guidelines for secondary prevention suggest lifestyle
changes such as smoking cessation, increase of physical
activity, weight management, risk factor control includ-
ing blood pressure control, lipid and diabetes manage-
ment, and pharmacological treatment for all persons
with CHD [8]. There is increasing evidence that elderly
men and women with CHD also benefit from secondary
prevention measures [9]. However, elderly persons are
more likely to have specific characteristics which may
complicate the implementation of secondary prevention
measures, e.g. the adherence to prescribed medication,
such as reduced social support, multimorbidity, func-
tional or cognitive impairments.
Secondary prevention after hospital discharge in Germany
is provided by a number of actors within the health care
system, specifically by general health practitioners and
cardiologists. Around 50% of the German patients with
an AMI receive an in-hospital cardiac rehabilitation
over a period of 3 weeks in a specialized rehabilitation
hospital. However, data suggest that patients aged above
60 receive in-hospital cardiac rehabilitation less oftenthan younger persons [10]. Moreover, in Germany no
home-based early post-discharge programs are available
as compared to other countries [11]. Long-term disease-
management programs for patients with CHD are offered
by health insurance companies.
A number of intervention trials, mostly including per-
sons younger than 70 years, investigated whether a post-
discharge nurse-based case management may influence
patient readmission and other outcomes in CHD [12,13].
Although the results of prior studies showed a positive
effect on the process of care, survival, and functional
status or quality of life of patients with CHD these find-
ings cannot be generalized to higher age-groups. Very
few studies reported on case management programmes
in people older than 65 years and described the costs of
intervention [12-14].
Thus, the aim of the present study was to evaluate the
effect of a case management intervention by trained
nurses on the time to first unplanned readmission or
death in patients aged 65 years and older with myocardial
infarction as compared with standard care.
Methods
Trial design and participants
KORINNA (“Coronary infarction follow-up in the eld-
erly”) is a single-centre randomized two-armed parallel
group trial of patients aged 75 years and older hospital-
ized with an acute myocardial infarction. The allocation
ratio was 1:1.
Deviations from the study protocol include the decrease
of minimum age of participants from 75 to 65 years, based
on an unexpected low number of older aged persons
which became apparent in the first year of recruitment.
As a consequence, the study protocol was modified in co-
ordination with the study’s Advisory Board by setting the
minimum age of participants to 65 years. The recruitment
phase was expanded accordingly. In addition, 11 persons
(7 patients in the intervention group and 4 patients in the
control group) were excluded because they died or with-
drew consent before hospital discharge or did not meet
the inclusion criteria. This deviation from the protocol
was discussed with, and approved by the study’s Advisory
Board.
Patients aged 65 and older who were hospitalized with
a first or recurrent myocardial infarction between September
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care unit situated in the city of Augsburg, Southern
Germany, were included consecutively. Patients who were
in institutionalized care or planned to move into institu-
tional care or outside the study region within the next
months were excluded. Furthermore, patients with severe
comorbidity (e.g. terminal cancer) which was associated
with a life expectancy of < 1 year, and patients who were
not able to communicate in German language were ex-
cluded. Finally, patients who were unable or unwilling to
give written informed consent (e.g. patients with demen-
tia) could not be included in the study.
The study protocol was approved by the Ethics Com-
mittee at the Bavarian Chamber of Physicians (Date of
approval: 11.11.2008, Reference number: 08064). Fur-
thermore, the study was conducted in accordance to
German privacy law and in compliance with the Helsinki
Declaration. The trial was registered in the Current Con-
trolled Trials database in February 2009. Patients were
recruited from 08.09.2008 to 11.05.2010 and one-year
follow-up examinations took place from 29.09.2009 to
16.06.2011.
Interventions
The nurse-based intervention is a complex interven-
tion combining components from case-management
and disease-management. Case-management elements in-
clude the identification of individual care problems and
the facilitation of care coordination. Disease-management
elements cover the identification of problems regarding
management of cardiac risk factors and the provision of
information and individual education. Main topics of the
intervention were symptoms and management of heart
failure (dyspnea, oedema, liquid control, body weight con-
trol), symptoms of angina, falls, blood pressure, heart rate,
blood glucose, medication and medication adherence, de-
pressed mood, and general physical condition. The selection
of intervention’s components is based on the experiences
with nurse-based follow-up programs in heart failure pa-
tients [15] and AMI patients [16]. It could be demonstrated
that individual problem identification and corresponding
care coordination and education can be effective measures
to reduce readmission and death in CHD patients. Since
elderly persons with AMI are more likely to have clinical
and social risk factors that need specific consideration, it
was expected that they benefit from an individual follow-
up care.
Based on an assessment of these potential intervention
areas using a structured interview guide, the study nurse
estimated the need for an intervention and selected the
type of intervention (e.g. referral to the general practi-
tioner, individual education on medication use, contacts
to cardiac sports group). For instance, if the patient re-
ported that he/she fell down, the nurse may check thehome environment for any trip hazards and may advise
on its modification, may examine the patients’ walking
abilities and advises on training or supportive devices, or
may refer to the general practitioner in order to check
possible adverse medication effects. The standards for
conducting home visits and telephone calls, including
potential interventions for each area, were provided in a
standard operating procedures guide which has been de-
veloped by a multidisciplinary team consisting of the
principal investigators, the study physician and the study
nurses. The study nurses received a training on assess-
ments and interventions by the study physician and the
principle investigators. The intervention was tested and
revised in a pilot phase from 27.06.2008 to 21.07.2008 in
11 patients. During the entire study course a team mem-
ber joined selected intervention sessions as an observer
to get a picture of the guideline adherence and the com-
parability of the applied interventions among the study
nurses. Regular meetings among team members and study
nurses were used to discuss problems regarding assess-
ment and intervention and to enhance standardization.
The content and structure of home visits and telephone
calls were comparable, and primarily differed regarding lo-
cation and type of contact between the patient and nurse,
and the possibility to perform for example blood glucose
and blood pressure measurements.
The study design is shown in Figure 1. Briefly, after giv-
ing informed consent, all patients received a baseline as-
sessment during hospital stay shortly before discharge,
which was carried out by the study physician and a non-
advanced practice study nurse. Those who were subse-
quently randomized to the intervention group received
the intervention starting with the initial session shortly be-
fore discharge (for details see [17]).
In this session the patient was provided with informa-
tion about the disease and comorbidities, about medica-
tion and with behavioural recommendations (nutrition,
physical activity, smoking etc.). Information was given
orally and in written form (so-called “heart book”). A
first home visit was arranged 7 to 14 days after dis-
charge, if accepted by the patient, otherwise an appoint-
ment for a telephone call was made. If the patient stayed
in a rehabilitation hospital immediately after discharge
from the Augsburg hospital, the first home visit was
postponed accordingly.
Home visits (0 to 4) and telephone calls (at least every
3 months) were carried out according to patient need
and patient risk level, which was assessed by the study
nurse during the first home visit based on compliance,
the social network, and the comorbidities. The risk level
classification suggested by Russell et al. [18] was applied.
Patients with New York Heart Association (NYHA)
Classification class 1 or 2 who showed good compliance



















Figure 1 Study design.
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cial support at least one home visit was scheduled. Par-
ticipants with NYHA classes 3 or 4 were planned to
receive at least 2–3 home visits if they had limitations re-
garding compliance or social support or no impairments.
In case patients with NYHA class 3 or 4 were lacking
compliance and social support, at least 4 home visits were
scheduled.
Outcomes
The primary endpoint was measured as time between
initial hospital discharge and first unplanned readmission
to hospital or death. Readmission was defined as admis-
sion to any hospital after discharge from the index hos-
pital. Only hospital stays with duration of at least 24 hours
were included. In standardized non-interventional tele-
phone interviews performed by study nurses with the pa-
tients in both groups at 3, 6, and 9 and 12 months after
index hospital discharge patient’s readmissions, acute care
visits to physicians, clinics, and ambulatory departments
were identified. Self-reported readmissions were valida-
ted by hospital records and the study physician decided
whether the readmissions were planned or unplanned
ones. Blinding of the study physician was maintained.
Outcome on all-cause mortality was determined from
death certificates, which were obtained from the local
health departments. After 12 months a follow-up exam-
ination was conducted.
The secondary endpoints of the KORINNA trial com-
prised clinical parameters such as blood pressure or lipid
parameters, as well as functional capacity, nutritional
risk, cognitive functioning, depression, and health-
related quality of life. Functional ability was assessedusing three different questionnaires: the Barthel Index
[19], the Health Assessment Questionnaire (HAQ-DI)
[20], and the Instrumental Activities of Daily Living Scale
(IADL) [21]. Social support was assessed by using a ques-
tionnaire (F-sozU) [22], depressive symptoms were
assessed by the Geriatric Depression Scale (GDS) [23],
emotional well-being by the WHO-5 Well Being Index
(WHO-5) [24], and cognitive function was measured
by using the Mini Mental State Exam (MMSE) [25]. These
instruments are described in more detail elsewhere
[17]. The results are already submitted for publication
elsewhere.
Another secondary outcome was the estimation of the
cost-utility ratio of the case management intervention.
Data for the economic analysis was collected by patient
report and hospital records. Data on resource utilization
was collected quarterly using a self- developed question-
naire based on available instruments such as the RAI
(Resident Assessment Instrument) [26] or the RUD (Re-
source utilization of dementia) [27] and own experi-
ences. Costs for the intervention excluding the costs
caused by the study were calculated. Cost components
included labor costs, travel expenses, telephone costs
etc. In order to calculate quality-adjusted life years
(QALYs), the EQ-5D questionnaire [28] was applied at
baseline, at interim telephone contacts, and during the
final assessment. Moreover, the Visual Analogue Scale
(VAS) [28] was applied at baseline and final assessment.
A cost-utility-analysis from the societal perspective in-
cluding the incremental cost-effectiveness ratio (ICER)
will be performed. More detailed information on the
economic analysis is given elsewhere. The analysis is on-
going and results will be published elsewhere.
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An event rate (readmission or death) of 40% in the con-
trol group was expected based on a comparable study
with patients aged 70 years [16]. Our trial was designed
to have at least 80% power to detect an improved rate of
25% in the intervention group (i.e. Δ = 0.15) at a two-
sided type I error level of 5%. Thus, at least 152 patients
per group were needed. We expected a drop-out rate
not exceeding 10% during the 1-year follow-up period.
In order to allow for loss to follow-up (patient withdrawing
consent or moving away from study region), it was planned
to recruit a total of 338 patients.
Randomization
A randomization procedure using randomized blocks
within strata was applied in order to achieve balanced
treatment groups with respect to gender, age (< 70 vs.
70–79 vs. 80+), and number of comorbidities (diabetes
and chronic heart failure). In order to ensure the con-
cealment of the allocation, randomization was provided
per telephone call to the biostatistical center at the
Helmholtz Zentrum München where a randomization
list was kept. Blinding of participants was not possible
because home visits were only offered for participants
from the intervention group. However, the persons who
performed the final assessment after 1 year and the person
who validated data on readmissions remained blinded
towards the patient’s group assignment.
Statistical methods
The primary analyses were conducted according to the
intention-to-treat approach. Kaplan Meier curves were
used to display the differences between the intervention
and the control group regarding the time to event (i.e. till
the first unplanned readmission or death). Cox propor-
tional hazards regression was used to quantify the effect
of intervention. For adjustment, the variables diabetes,
heart failure, age and gender were included as inde-
pendent variables into the Cox regression models. Sub-
group analyses were performed for high risk groups (i.e.
subjects aged 75 and above, subjects with diabetes, sub-
jects with at least one comorbid condition) and for sex.
As sensitivity analysis, the first six weeks were disre-
garded (i.e. the observation time started at day 42 after
discharge), to approximate the time period since the
first home visit.
Results
In all, 636 patients were screened for participation in the
study. Of those, 296 patients were not included as they
did not wish to participate (n=92), did not fulfill the in-
clusion criteria (n=180) or met other exclusion criteria
(n=24). Thus, 340 patients were included and underwent
randomization to follow-up for one year within thenurse-based management (intervention group) or to usual
care (control group). After randomization, 11 persons
(7 patients in the intervention group and 4 patients in the
control group) were excluded because they died or with-
drew consent before hospital discharge or did not meet
the inclusion criteria. Thus, 161 persons started the allo-
cated intervention and 168 individuals received usual care
(see Figure 2).
Baseline characteristics
The baseline characteristics of the 329 participating pa-
tients are shown in Table 1. The two groups were well
matched for gender and age. The mean age of the overall
sample was 75.4 (± 6.0) years. In the intervention group,
29.8% of the patients suffered from heart failure and
28.0% had diabetes; the corresponding percentages in
the control group were 28.0% and 36.3%. Intervention
and usual care patients did not differ regarding the
scores, mean BMI and diastolic blood pressure at base-
line examination. The mean systolic blood pressure was
121.6 mmHg in the intervention group in comparison to
124.2 mmHg in the control group.
Altogether 132 of the 161 patients (82%) in the inter-
vention group accepted a first home visit; during the
follow-up period of one year 186 home visits were car-
ried out (104 patients received 1 visit, 10 patients re-
ceived 2 visits, 11 patients received 3 visits, 6 patients
received 4 visits, and 1 patient received 5 home visits). A
home visit lasted 117 minutes on average. Furthermore,
in the intervention group, 489 telephone appointments
were made, that is, 161 patients received on average 3
telephone appointments. The mean length of a tele-
phone session was 19 minutes. Topics of the discussions
with the patients in the intervention group were symp-
toms and management of heart failure, symptoms of an-
gina, falls, control of blood pressure, heart rate, and
blood glucose, medication and medication adherence,
depressed mood, and general physical condition.
Observed events
The mean follow-up time for the intervention group was
273.6 days, and for the control group it was 320.6 days.
During the follow-up period, 140 patients had an event
(i.e. first unplanned readmission or death). Sixty-two of
these were in the intervention group and 78 in the con-
trol group. In the intervention group 57 of the events
were first unplanned readmissions and 5 were deaths,
while in the control group 75 of the events were first un-
planned readmissions and 3 were deaths. Furthermore,
13 patients in the intervention group and 10 patients in
the control group of those with unplanned readmissions
died within the follow-up period.
Many events appeared within the first two months
after discharge. Within the first 60 days after discharge







Mean age, years (SD) 75.2 (6.0) 75.6 (6.0)
Male sex, % (n) 62.7% (101) 61.3% (103)
Diabetes mellitus, % (n) 28.0% (45) 36.3% (61)
Congestive heart failure, % (n) 29.8% (48) 28.0% (47)
Blood pressure, mean (SD)*
Systolic BP, mmHg 121.6 (13.7) 124.2 (13.5)
Diastolic BP, mmHg 71.4 (7.8) 71.3 (8.3)
BMI (kg/m2), mean (SD)* 27.7 (4.2) 27.3 (3.9)
Physical/mental health,
mean (SD)*
HAQ-DI score 0.8 (0.8) 0.8 (0.8)
Barthel-index 90.8 (17.1) 90.8 (17.5)
IADL-Score 5.6 (1.6) 5.6 (1.5)
MMST 26.7 (4.1) 26.4 (3.8)
GDS 3.2 (3.1) 3.2 (2.6)
Social support 3.9 (0.6) 3.9 (0.6)
WHO-5-well-being index 13.6 (6.8) 13.2 (6.9)
*Due to missing values, the number of observations ranges between 155 and
161 in the intervention, and 161 and 167 in the control group.
Figure 2 Flow of participants through the KORINNA trial.
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events within the control group. Of these 29 events in the
intervention group and 27 events in the control group
were unplanned readmissions and 5 in the intervention
group and 1 in the control group were deaths. Further-
more, 10 patients in the intervention group and 5 patients
in the control group of those with unplanned readmis-
sions died within the first 60 days after discharge.
During the follow-up period altogether 235 unplanned
admissions and 79 planned admissions to hospitals oc-
curred in the whole study group. Of those, there were 87
unplanned and 46 planned hospital stays in the interven-
tion group, and 148 unplanned and 33 planned hospital
stays in the control group. Eighty patients in the control
group and 85 patients in the intervention group had no
hospital stay during the one-year follow-up.
Figure 2 shows the time-to-event Kaplan-Meier-Curves
for the combined end point of unplanned readmissions
and death in the two study groups. No significant benefi-
cial effect for the intervention group in comparison to the
control group could be shown after one year (Hazard
Ratio 1.01, 95% confidence interval 0.72-1.41, Table 2).
However, the Kaplan Meier curves show a crossing which
favors the intervention group at the end of the follow-up
period.
Subgroup analysis
Figure 3 shows the survival curves for the combined end
point for the whole study group and Figure 4 shows the
survival curves stratified by sex. After one year, neither
in men nor in women significant differences between











0.07 0.17 1.01 0.72; 1.41 0.969
Diabetes 0.38 0.18 1.46 1.02; 2.09 0.039
Heart failure 0.35 0.19 1.42 0.99; 2.04 0.060
Age 0.06 0.02 1.06 1.03; 1.10 <.001
Male −0.21 0.19 0.81 0.56; 1.17 0.264
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served. In male participants the same pattern with a
cross in favour of the intervention group could be ob-
served (Figure 4 top). However, in women the interven-
tion group seems to have a beneficial but insignificant
effect right from the start (Figure 4 bottom).
No significant beneficial effects of the intervention on
the end point unplanned readmissions and death were
consistently found in further subgroup analyses. While
the crossing in favour of the intervention group could be
observed among the subgroup of diabetic persons, per-
sons living alone, and persons with at least one comor-
bid condition, in the subgroup analysis including
patients aged > 75 years this pattern was not found (data
not shown).Figure 4 top: Kaplan Meier curve until first unplanned
readmission to hospital or death (men), bottom: Kaplan Meier
curve until first unplanned readmission to hospital or
death (women).Sensitivity analysis
As sensitivity analysis, the first six weeks were disre-
garded, to approximate the time period since the first
home visit. In this analysis adjusted for diabetes, heart
failure, age, and gender, regarding the time to first un-
planned hospitalization or death also no significant
beneficial effect for the intervention group in compari-































Figure 3 Kaplan Meier curve until first unplanned readmission
to hospital or death (total sample).(Hazard Ratio 0.90, 95% confidence interval 0.62-1.29,
p-value 0.556).
Discussion
In the present study, no significant beneficial effect of a
case management intervention by trained nurses on the
time to first unplanned readmission or death within one
year after discharge in patients 65 years and older with
myocardial infarction as compared with standard care
could be shown. Furthermore, in subgroup analysis no
patient group with a significant benefit from the interven-
tion could be identified. However, because the Kaplan
Meier curves show a crossing in favor of the intervention
group during follow-up a delayed positive effect of the
case management intervention by trained nurses might be
possible.
So far, a lot of intervention trials investigated the effect
of a nurse-based case management on the frequency of
readmissions and other outcomes in persons with CHD
[12,13]. In a meta-analysis including 63 randomized trials
by Clark et al. the impact of secondary prevention pro-
grams with and without exercise components in patients
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vestigated [12]. It could be shown that secondary preven-
tion programs have a positive effect on process of care
and functional status or quality of life and reduce MIs.
The found mortality benefit became stronger with longer
follow-up (24 months) and the advantages were independ-
ent of the key components of the respective interventions.
In a review including 12 randomized trials conducted
in persons mainly younger than 70 years the effect of
case management programmes for patients with estab-
lished CHD on the process of care and mortality was ex-
amined [13]. It was found that multidisciplinary disease
management programmes for secondary prevention have
a beneficial effect on process of care in patients with
CHD. With the case management programmes it was
possible to significantly reduce admissions to hospital
and to improve quality of life. However, these random-
ized clinical trials failed to show any survival benefit or
reduction in recurrent MI. Furthermore, the duration of
intervention and length of follow-up had no effect on
the observed results.
The results of these studies are promising, but the
findings cannot be generalized to higher age-groups.
Only very few studies investigating the benefit of case
management programmes included persons older than
65 years. For example, Naylor et al. [14] examined whe-
ther a comprehensive discharge planning and home
follow-up intervention in elderly hospitalized persons
(mean age 75 years) at high risk for rehospitalisation by
advanced practice nurses has an effect on outcomes. It
could be demonstrated that such an intervention can re-
duce readmissions, lengthen the time between discharge
and readmission, and decrease the costs of providing
health care in older patients with one of several medical
and surgical reasons for admission [14].
In the KORINNA study older patients with myocardial
infarction, who have often been excluded from randomized
controlled trials were included. Contrary to the results of
most of the prior studies we could not demonstrate a sig-
nificant effect of the nurse-based intervention on the pri-
mary outcome during the one year follow-up in this
patient group. The reasons for a missing significant benefit
for the persons managed in the intervention group are not
clear. Possibly, the study period of 12 months was too
short to show a clear impact on readmissions and mortal-
ity. This assumption can be corroborated by the fact that
the survival curves cross during follow-up in favour of the
intervention group, which could point to a delayed effect
of the case management by study nurses. As an effect of
the nursing intervention one could imagine that patients
first become more sensitive to potential harmful changes
of their health status which might explain the observed
higher number of hospital readmissions in the first four
months of the study period. This increased awareness,however, might be associated with a higher treatment ad-
herence that could positively affect long-term outcomes.
At the moment it is unclear whether there could be a
significantly positive long-term intervention effect on
readmission to hospital or death in the present study.
However, we were able to get additional funding for an
extension and data from the 3-year follow-up will be
used to further elucidate this question.
In addition, it is not clear whether the timing of the
interventions was optimal to increase their effectiveness.
Perhaps more frequent interventions in the first two
months would be more useful. However, systematic re-
views so far could not identify intervention schedules
which were particularly effective, thus, further research
is warranted [13,29].
Of interest, women assigned to the intervention group,
showed a tendency for less hospital readmissions and
better survival compared with the control group from
the beginning of the study whereas in men the typical
cross of survival curves was found. Considering results
from studies which indicate that gender-specific second-
ary prevention programs are more effective than unspe-
cific ones [30], one can speculate that the intervention
applied in the KORINNA study may include modules
which have a greater short-term benefit in women than
in men. Thus, it is essential that a more detailed analysis
of the differential impact of the intervention program
will be performed. Moreover, it is thinkable, that disease
management programmes may be most beneficial in
those settings where usual care is suboptimal. Hence, it
could be assumed, that in the present study the incre-
mental benefit of the nurse-based management over the
usual care group may be very small because the manage-
ment in the usual care arm may be close to optimal
already. Furthermore, another explanation for the miss-
ing benefit for the intervention group might be that on
the patient level the intervention had no significant, sus-
tainable impact on the behaviour of the patients. In
addition, it is thinkable that our study is not comparable
to other randomized controlled trials on this issue con-
ducted in other countries or settings due to differences
in the kind of intervention, standard care and study end-
points. In a systematic review including twenty-one ran-
domized clinical trials of transitional care interventions
targeting chronically ill adults Naylor et al. found a sub-
stantial heterogeneity in the populations, settings, inter-
ventions and methodologies, which could influence the
study results. The authors of that study have identified
three proven strategies that have effectively reduced all-
cause readmissions through six of twelve months. It was
concluded that many of the successful interventions
shared similar features and recommended several strat-
egies to guide the implementation of transitional care [31].
Olson et al. found in their systematic review including 62
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consistently demonstrate that any specific intervention re-
sulted in improved patient- or system-based outcomes.
Thus, more consensus is needed on the definition of the
interventions and the outcomes appropriate to those inter-
ventions [32].
A possible limitation of the study design is the rela-
tively short follow-up interval of one year. Hospital read-
missions were determined based on patient self-reports
and may be biased. The generalizability of our results is
limited to elderly patients with a myocardial infarction
and may not apply to other populations. A further limi-
tation of the study is its single center design. Further-
more, only 340 out of the 636 patients assessed for
eligibility participated in the study, 21% (92 of 432) de-
clined to participate prior to randomization, and another
10% (34 of 331) withdrew consent after randomization.
If there were systematic differences between the ex-
cluded patients and those randomized to the trial, the
external validity of the present findings may be reduced.
Conclusions
In summary, the KORINNA study showed that a nurse-
based management over one year did not seem to sig-
nificantly influence unplanned readmissions to hospital
or out of hospital deaths in comparison to usual care in
older myocardial infarction patients. Whether such an
intervention could have a long-term influence on these
outcomes should be the focus of further studies.
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